Why Partner with Us

Robust global networks

A truly global company, connecting over 30 countries

Multiple areas of opportunity

From co-developing drugs to out-licensing – collaboration is key

Legacy of results and delivery

Over 25 years of forwarding science at Dr. Reddy’s Biologics

Our Network of Partners

  • All
  • In-licensing
  • Out-licensing
  • Co-development
Alvotech
Healthcare Pharmaceuticals Limited
Coya Therapeutics

Processes Involved Toward Partnership

Please expect to go through the following processes on the way to successful deal closure. 

Write to us using the Enquiry Form below.

Non-Disclosure Agreement (NDA):
Business Case and Opportunity Assessment:
Term Sheet:
Due Diligence:
Licensing Agreement:
Supporting Agreements:
0/40
0/40
0/250

Our Network

Our News, Stories, and Insights

Zydus
  • News
  • 28-06-2024

Zydus Life, Dr Reddy's partner to co-market Pertuzumab biosimilar for breast cancer treatment

  • News
  • 12-06-2024

Aurigene Pharma announces opening of biologics facility in Genome Valley

  • News
  • 22-05-2024

Dr Reddy's inks licencing agreement with Alvotech

  • News
  • 21-05-2024

Alvotech and Dr. Reddy’s enter into collaboration for its biosimilar to treat osteoporosis

Bricks of Biologics, appreciates the contribution and celebrates our people who are the building blocks of Dr. Reddy's Biologics.

 

Bricks of biologics in general refers to bio-bricks as genetic building blocks which are DNA sequences that can be assembled to create complex biological systems.